Literature DB >> 1360612

The effect of beta blocking drugs on lipid peroxidation in rat heart in vitro.

R R Jenkins1, C M Del Signore, P Sauer, C Skelly.   

Abstract

Beta-adrenergic receptor blocking drugs include a structurally related class of drugs that are employed clinically to treat a variety of cardiovascular disorders. Since these drugs exert additional nonspecific effects including membrane stabilization, representative samples including atenolol, dilevolol, labetalol, metoprolol and propranolol were studied to determine their influence on lipid peroxidation. Homogenates or liposomes of adult rat hearts were incubated in the presence of various concentrations of propranolol or equivalent concentrations of dilevolol, labetalol, metoprolol or atenolol. Lipid peroxidation was stimulated with 50 microM FeSO4, 5 microM t-butyl hydroperoxide (homogenates) or 0.2 mM citrate FeSO4 (liposomes) plus O2. Lipid peroxidation, as assessed by both the thiobarbituric acid reaction and chemiluminescence, was reduced in a dose-dependent manner as the propranolol concentration was increased from 1 to 10 mM. The five beta-adrenergic receptor blocking drugs reduced lipid peroxidation both in crude homogenates and in liposomes; their effectiveness was related to their lipophilicity. Dilevolol, propranolol, labetalol and metoprolol at a concentration of 20 mM reduced lipid peroxidation by 45%, 37%, 35% and 28%, respectively. The hydrophilic blocker atenolol was ineffective in reducing lipid peroxidation even at elevated concentrations. Lipophilic beta-blocking drugs apparently are capable of exerting an antioxidant effect in protecting membrane lipids against peroxidation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360612     DOI: 10.1007/bf02536137

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  30 in total

1.  THE ANTIARRHYTHMIC ACTIONS OF BETA ADRENERGIC BLOCKING AGENTS.

Authors:  P SOMANI; B K LUM
Journal:  J Pharmacol Exp Ther       Date:  1965-02       Impact factor: 4.030

Review 2.  Vitamin E: antioxidant activity, biokinetics, and bioavailability.

Authors:  G W Burton; M G Traber
Journal:  Annu Rev Nutr       Date:  1990       Impact factor: 11.848

3.  An investigation into the mechanism of citrate-Fe2+-dependent lipid peroxidation.

Authors:  G Minotti; S D Aust
Journal:  Free Radic Biol Med       Date:  1987       Impact factor: 7.376

4.  Ultraweak chemiluminescence: a sensitive assay for oxidative radical reactions.

Authors:  A Boveris; E Cadenas; B Chance
Journal:  Fed Proc       Date:  1981-02

5.  The action of beta-adrenoceptor antagonists on rat heart mitochondrial function in vitro: a comparison of propranolol, timolol, and atenolol.

Authors:  P J Quinn; E C Crutcher
Journal:  Cardiovasc Res       Date:  1984-04       Impact factor: 10.787

6.  Effect of cardioplegic solution and of propranolol on perioperative infarction after cardiac surgery for unstable angina.

Authors:  N L Poirier; P J Belliveau; J E Wynands
Journal:  Can J Surg       Date:  1980-07       Impact factor: 2.089

7.  Microsomal electron transport. The role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in liver microsomal lipid peroxidation.

Authors:  T C Pederson; J A Buege; S D Aust
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

8.  Beta-blocker brain concentrations in man.

Authors:  J M Cruickshank; G Neil-Dwyer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Anticonvulsant effects of propranolol and their pharmacological modulation.

Authors:  W Fischer; R Lasek; M Müller
Journal:  Pol J Pharmacol Pharm       Date:  1985 Nov-Dec

10.  Propranolol in acute myocardial infarction: the MILIS experience.

Authors:  R E Rude; L M Buja; J T Willerson
Journal:  Am J Cardiol       Date:  1986-04-25       Impact factor: 2.778

View more
  3 in total

1.  Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.

Authors:  Eikan Mishima; Emiko Sato; Junya Ito; Ken-Ichi Yamada; Chitose Suzuki; Yoshitsugu Oikawa; Tetsuro Matsuhashi; Koichi Kikuchi; Takafumi Toyohara; Takehiro Suzuki; Sadayoshi Ito; Kiyotaka Nakagawa; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2019-11-25       Impact factor: 10.121

2.  Comparison of Carvedilol and Metoprolol for Preventing Contrast-Induced Nephropathy after Coronary Angiography.

Authors:  Mustafa Yılmaz; Alp Aydınalp; Kaan Okyay; Abdullah Tekin; Uğur Abbas Bal; Nilüfer Bayraktar; Aylin Yıldırır; Haldun Müderrisoğlu
Journal:  Cardiorenal Med       Date:  2015-05-30       Impact factor: 2.041

3.  A clinical study about contrast nephropathy: risk factors and the role of beta blockers.

Authors:  Çağdaş Akgüllü; Ufuk Eryılmaz; Hasan Güngör; Ahmet Huyut; Cemil Zencir; Tolga Hekim
Journal:  Anatol J Cardiol       Date:  2014-04-28       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.